Literature DB >> 35962988

A Spatial Attention Guided Deep Learning System for Prediction of Pathological Complete Response Using Breast Cancer Histopathology Images.

Hongyi Duanmu1, Shristi Bhattarai2, Hongxiao Li3, Zhan Shi1, Fusheng Wang1,4, George Teodoro5, Keerthi Gogineni6,7,8, Preeti Subhedar8, Umay Kiraz9, Emiel A M Janssen9,10, Ritu Aneja11, Jun Kong3,12.   

Abstract

MOTIVATION: Predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients accurately is direly needed for clinical decision making. pCR is also regarded as a strong predictor of overall survival. In this work, we propose a deep learning system to predict pCR to NAC based on serial pathology images stained with hematoxylin and eosin (H&E) and two immunohistochemical biomarkers (Ki67 and PHH3). To support human prior domain knowledge based guidance and enhance interpretability of the deep learning system, we introduce a human knowledge derived spatial attention mechanism to inform deep learning models of informative tissue areas of interest. For each patient, three serial breast tumor tissue sections from biopsy blocks were sectioned, stained in three different stains, and integrated. The resulting comprehensive attention information from the image triplets is used to guide our prediction system for prognostic tissue regions.
RESULTS: The experimental dataset consists of 26,419 pathology image patches of 1,000×1,000 pixels from 73 TNBC patients treated with NAC. Image patches from randomly selected 43 patients are used as a training dataset and images patches from the rest 30 are used as a testing dataset. By the maximum voting from patch-level results, our proposed model achieves a 93% patient-level accuracy, outperforming baselines and other state-of-the-art systems, suggesting its high potential for clinical decision making. AVAILABILITY: The codes, the documentation, and example data are available on an open source at: https://github.com/jkonglab/PCR_Prediction_Serial_WSIs_biomarkers.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2022        PMID: 35962988      PMCID: PMC9525016          DOI: 10.1093/bioinformatics/btac558

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.931


  24 in total

1.  Quantification of histochemical staining by color deconvolution.

Authors:  A C Ruifrok; D A Johnston
Journal:  Anal Quant Cytol Histol       Date:  2001-08       Impact factor: 0.302

2.  Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.

Authors:  Jennifer F De Los Santos; Alan Cantor; Keith D Amos; Andres Forero; Mehra Golshan; Janet K Horton; Clifford A Hudis; Nola M Hylton; Kandace McGuire; Funda Meric-Bernstam; Ingrid M Meszoely; Rita Nanda; E Shelley Hwang
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

Review 3.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

4.  Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.

Authors:  Diane Goltz; Matteo Montani; Martin Braun; Sven Perner; Nicolas Wernert; Klaus Jung; Manfred Dietel; Carsten Stephan; Glen Kristiansen
Journal:  Pathology       Date:  2015-12       Impact factor: 5.306

5.  Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

Authors:  Gunter von Minckwitz; Michael Untch; Jens-Uwe Blohmer; Serban D Costa; Holger Eidtmann; Peter A Fasching; Bernd Gerber; Wolfgang Eiermann; Jörn Hilfrich; Jens Huober; Christian Jackisch; Manfred Kaufmann; Gottfried E Konecny; Carsten Denkert; Valentina Nekljudova; Keyur Mehta; Sibylle Loibl
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

6.  Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.

Authors:  Sang Hee Park; Woo Kyung Moon; Nariya Cho; Jung Min Chang; Seock-Ah Im; In Ae Park; Keon Wook Kang; Wonshik Han; Dong-Young Noh
Journal:  Eur Radiol       Date:  2011-08-16       Impact factor: 5.315

Review 7.  Deep Learning in Medical Image Analysis.

Authors:  Dinggang Shen; Guorong Wu; Heung-Il Suk
Journal:  Annu Rev Biomed Eng       Date:  2017-03-09       Impact factor: 9.590

Review 8.  The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.

Authors:  Yan Mao; Qing Qu; Yuzi Zhang; Junjun Liu; Xiaosong Chen; Kunwei Shen
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

9.  Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Authors:  H Raza Ali; Aliakbar Dariush; Elena Provenzano; Helen Bardwell; Jean E Abraham; Mahesh Iddawela; Anne-Laure Vallier; Louise Hiller; Janet A Dunn; Sarah J Bowden; Tamas Hickish; Karen McAdam; Stephen Houston; Mike J Irwin; Paul D P Pharoah; James D Brenton; Nicholas A Walton; Helena M Earl; Carlos Caldas
Journal:  Breast Cancer Res       Date:  2016-02-16       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.